Nicoletta Sacchi

Q: What Schools Are Affiliated With Nicoletta Sacchi

Nicoletta Sacchi is affiliated with the following schools: University of Milan, Massachusetts General Hospital

Nicoletta Sacchi's AcademicInfluence.com Rankings

Nicoletta Sacchi

Medical

#3634

World Rank

#4119

Historical Rank

Oncology

#257

World Rank

#265

Historical Rank

medical Degrees

Nicoletta Sacchi

Philosophy

#11611

World Rank

#16024

Historical Rank

Logic

#8412

World Rank

#10522

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Nicoletta Sacchi's Degrees

Doctorate Medicine University of Milan
PhD Oncology University of Milan

Why Is Nicoletta Sacchi Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Nicoletta Sacchi is an Italian professor of oncology at the Roswell Park Comprehensive Cancer Center. She is the co-discoverer of the acid guanidinium thiocyanate-phenol-chloroform extraction method to extract RNA from biological samples with Trizol. As a consequence of this groundbreaking discovery she is now considered the most cited woman scientist in the world.

(See a Problem?)

Nicoletta Sacchi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genomewide Association Study of Severe Covid-19 with Respiratory Failure (2020) (1425)
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). (2001) (458)
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. (2001) (372)
Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR (2001) (348)
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. (2006) (306)
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. (2008) (267)
Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells (2000) (215)
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. (2002) (174)
Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and (8;21) translocations. (1986) (171)
Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling (2003) (167)
Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. (1992) (162)
Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung (2004) (150)
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. (2009) (130)
Atrophin-1, the Dentato-Rubral and Pallido-Luysian Atrophy Gene Product, Interacts with Eto/Mtg8 in the Nuclear Matrix and Represses Transcription (2000) (113)
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors (2002) (100)
Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P. (1999) (95)
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19 (2020) (79)
Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia. (2018) (76)
HLA polymorphisms in Italian bone marrow donors: a regional analysis. (1998) (75)
Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. (2005) (72)
Impaired Retinoic Acid (RA) Signal Leads to RARβ2 Epigenetic Silencing and RA Resistance (2005) (72)
Comparative mapping of DNA markers from the familial Alzheimer disease and Down syndrome regions of human chromosome 21 to mouse chromosomes 16 and 17. (1988) (71)
Definitions of histocompatibility typing terms. (2011) (70)
Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0 (2020) (66)
Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes (2012) (60)
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry (2009) (51)
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health (2008) (51)
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants (2010) (50)
ACCELERATED DISCOVERY Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas (2000) (49)
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience (1997) (44)
Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits. (2010) (44)
Estimation of human leukocyte antigen class I and class II high-resolution allele and haplotype frequencies in the Italian population and comparison with other European populations. (2012) (43)
Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. (1995) (43)
RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis (2013) (41)
The MTG proteins: chromatin repression players with a passion for networking. (2004) (41)
AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts (1994) (41)
The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases. (2010) (41)
In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS‐275 in retinoid‐resistant prostate cancer cells (2005) (41)
Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. (2003) (40)
The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies (2002) (39)
The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations. (1990) (39)
RAR-mediated epigenetic control of the cytochrome P450 Cyp26a1 in embryocarcinoma cells (2006) (37)
The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo (2013) (35)
Chronic GVHD is associated with inferior relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors (2012) (34)
Sasa health exerts a protective effect on Her2/NeuN mammary tumorigenesis. (2004) (34)
Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid (2007) (33)
Derangement of a Factor Upstream of RARα Triggers the Repression of a Pleiotropic Epigenetic Network (2009) (33)
ETS family of genes in leukemia and Down syndrome. (2005) (32)
Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia. (1995) (31)
DNA sequences of chromosome 21-specific YAC detect the t(8;21) breakpoint of acute myelogenous leukemia. (1991) (31)
A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk. (2006) (31)
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide. (2018) (31)
Physical mapping of the human chromosome 11q23 region containing the ataxia-telangiectasia locus. (1990) (30)
Role of the HLA Class II (2007) (29)
The ETS genes on chromosome 21 are distal to the breakpoint of the acute myelogenous leukemia translocation (8;21). (1988) (29)
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission (2003) (28)
The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/*02:02 mismatches in unrelated hematopoietic SCT (2011) (28)
High expression of ets-1 gene in human thymocytes and immature T leukemic cells. (1988) (28)
Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis (2012) (28)
Definitions of histocompatibility typing terms: Harmonization of Histocompatibility Typing Terms Working Group. (2011) (28)
Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO). (1996) (28)
Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant clone (1997) (26)
Subcellular localization of the oncoprotein MTG8 (CDR/ETO) in neural cells (1998) (26)
Validation of the acute leukemia‐EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi‐center GITMO cohort (2017) (25)
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment (2021) (24)
Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation. (2007) (24)
Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients (1998) (23)
A stable marker chromosome with a cryptic centromere: evidence for centromeric sequences associated with an inverted duplication. (1996) (23)
Loss of MTG16a (CBFA2T3), a novel rDNA repressor, leads to increased ribogenesis and disruption of breast acinar morphogenesis (2009) (23)
Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation (2005) (23)
Hu-ets-2 is translocated to chromosome 8 in the t(8;21) in acute myelogenous leukemia. (1986) (22)
Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop. (2019) (22)
Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products (2010) (21)
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. (2007) (20)
Phorbol ester-induced changes in human leukemic pre-B lines. (1984) (20)
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes (2009) (20)
Down syndrome and chromosome 21 abnormalities in leukaemia. (1992) (19)
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia (2015) (19)
Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin (2000) (18)
Home range overlapping and socio-sexual relationships in the red-backed shrike Lanius collurio (1994) (16)
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients (2012) (15)
Human ETS2 gene on chromosome 21 is not rearranged in Alzheimer disease. (1988) (15)
Lack of evidence for association of meiotic nondisjunction with particular DNA haplotypes on chromosome 21. (1988) (15)
Single-cell detection of ets-1 transcripts in human neuroectodermal cells. (1991) (15)
Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery (2016) (14)
Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia. (1996) (14)
Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome (2007) (13)
Strategies of the donor search for children with second CR ALL lacking a matched sibling donor (2008) (13)
Clinical relevance of terminal transferase and adenosine deaminase in leukemia. (1982) (13)
Transcriptionally active chimeric gene derived from the fusion of the AML gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. (1993) (12)
Novel RNA-binding properties of the MTG chromatin regulatory proteins (2008) (11)
The avian and mammalian ets genes: molecular characterization, chromosome mapping, and implication in human leukemia. (1986) (11)
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey) (2021) (11)
17th IHIW component "Immunogenetics of Ageing" - New NGS data. (2019) (11)
A distinct epigenetic signature at targets of a leukemia protein (2007) (11)
3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms (2019) (10)
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortality (2006) (10)
Oncogenes: molecular probes for clinical application in malignant diseases. (1986) (10)
Quality of harvest and role of cell dose in unrelated bone marrow transplantation: An Italian Bone Marrow Donor Registry–Gruppo Italiano Trapianto di Midollo Osseo Study (2014) (10)
The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy (2017) (10)
Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARa epigenetic mechanism of mammary epithelial cell fate (2016) (10)
Acquisition of deoxyguanosine resistance by TPA-induced T lymphoid lines. (1983) (10)
CSF1R (colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog) (2011) (10)
Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer (2017) (10)
DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells. (1996) (9)
Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. (2016) (9)
Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine (2022) (9)
High‐resolution analysis of the HLA‐A, ‐B, ‐C and ‐DRB1 alleles and national and regional haplotype frequencies based on 120 926 volunteers from the Italian Bone Marrow Donor Registry (2019) (9)
Molecular structure and evolution of DNA sequences located at the alpha satellite boundary of chromosome 20. (2000) (9)
Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid (2020) (8)
Training practices of hematopoietic progenitor cell–apheresis and –cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation (2014) (7)
Genes on chromosome 21 and cancer. (1990) (7)
GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS (2021) (7)
High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint report. (2021) (7)
High efficiency in the attribution of parental origin of non-disjunction in trisomy 21 by both cytogenetic and molecular polymorphisms (1988) (7)
Qualifications and training of adult stem cell donor recruiters: recommendations by the World Marrow Donor Association (2013) (6)
Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020—Report from World Marrow Donor Association (2021) (5)
A registry of HLA‐typed donors for production of virus‐specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune‐compromised patients (2014) (5)
Is it time to re-think a sustainable banking model for the Italian Cord Blood Network? (2018) (5)
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study (2018) (5)
Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation (2020) (5)
MiR-221-regulated KIT level by wild type or leukemia mutant RUNX1: a determinant of single myeloblast fate decisions that – collectively – drives or hinders granulopoiesis (2017) (5)
HLA-A, -B and -DRB1 alleles in a population from Italy (2004) (5)
A polymorphic SstI site within the human ets-1 gene in the 11q23 region. (1986) (4)
The cellular ets genes: molecular biology and clinical implications in human leukemias. (1986) (4)
Non-Permissive HLA-DPB1 Disparity is a Significant Independent Risk Factor for Mortality after Unrelated Hematopoietic Stem Cell Transplantation Running Title: Nonpermissive HLA-DPB1 disparity in unrelated HSCT (2009) (4)
Molecular evolution of ets genes from avians to mammals and their cytogenetic localization to regions involved in leukemia. (1986) (4)
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01 (2022) (4)
170-P: Non-permissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation (2009) (4)
[The Italian Registry of Bone Marrow Donors: genetic structure and recruitment strategy]. (1999) (4)
Disappearance of nuclear TdT in RPMI-8402 following TPA treatment. (1982) (3)
Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia (2012) (3)
Bone marrow transplantation from unrelated donors : the Italian experience (1993) (3)
A duplication-deficiency X chromosome in a girl with severe mental retardation (2004) (3)
Loss of MTG16a (CBFA2T3), a novel rDNA repressor, leads to increased ribogenesis and disruption of breast acinar morphogenesis (2010) (3)
Identification of a novel HLA‐C allele, C*02:10:03, in a Venezuelan patient (2018) (3)
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19 (2020) (2)
Abstract 2501: Proteomics signature of lack of retinoic acid signal surveillance at early breast cancer stages (2014) (2)
Functional marker chromosomes lacking detectable alpha satellite DNA: a tool for centromere study. (1998) (2)
Adaptation to hypertonicity and selection of cell hybrids. (1978) (2)
SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility (2021) (2)
Adenosine Deaminase and Terminal Transferase in Leukemic Cells (1983) (2)
The Intra-Bone Route of Administration of Cord blood cells extends the Possibility of Transplantation to the Majority of Patients with Malignant Hematopoietic Diseases. (2009) (2)
Biological Age versus Chronological Age in the Prevention of Age Associated Diseases (2019) (2)
Intercellular exchange of lysosomal hydrolases between mutant human fibroblasts and other cell types. (1980) (2)
DNA synthesis catalyzed in vitro by yeast extracts. (2005) (2)
Improved results in marrow transplantation from unrelated donors. Genoa BMT Group. (1999) (2)
[Genetic analysis of Italian hematologic patients candidates for bone marrow transplantation from unrelated donors]. (1999) (2)
Leukaemia in Down's syndrome. (1991) (2)
The ets Genes in Cells and Viruses: Implications for Leukemias and Other Human Diseases (1987) (1)
Pre-transplant CYA. Preliminary results of a randomized study in pediatric recipients of unrelated-donor BMT. (1999) (1)
Chromosome lesions in amniotic fluid cell cultures (1979) (1)
Silencing of the RARA epigenetic network reveals the tumor-promoting activity of vitamin A (2009) (1)
NON-Permissive HLA-DPB1 T CELL Epitope Disparities Correlate with Engraftment and Survival after Unrelated Stem Cell Transplantation (2008) (1)
The cellular ets genes: molecular probes in human neoplasia. (1987) (1)
A Randomized Trial of Rabbit Anti-Thymocyte Globulin, Given on Day+7 after Alternative Donor Transplants. (2006) (1)
[The Italian Registry of Bone Marrow Donors]. (1999) (1)
Long Term Follow up of Two Randomized Trials on Antithymocyte Globulin (ATG) for GVHD Prophylaxis in Unrelated Donor Transplants: Chronic GVHD, Bronchiolitis and Quality of Life. (2004) (1)
The heterogeneous scenario at the basis of RARβ2 epigenetic silencing and RA resistance in breast epithelial cells (2006) (1)
Italian Bone Marrow Donor Registry (IBMDR). (1993) (1)
Unrelated Hematopoietic Stem Cell Transplantation with Reduced Intensity Regimens in High Risk Patients for Age or Disease: Results from Two Independent Prospective GITMO Studies. (2005) (1)
Polypeptide structure of human terminal transferase. (1982) (1)
ENHANCED ALLOREACTIVITY TO BI-DIRECTIONAL NON-PERMISSIVE HLA-DPB1 MISMATCHES SUPPORTS NON-HIERARCHICAL T-CELL EPITOPE GROUP DIVERSITY AS UNDERLYING BIOLOGICAL MECHANISM (2013) (1)
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population. (2021) (0)
Complementation test on cell variants to 8-Azaguanine and 6-thioguanine. Analysis of heterokaryons and cell hybrids (1977) (0)
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study (2023) (0)
The Mammalian ETS Genes: Two Unique Chromosomal Locations in Cat, Mice and Man and Novel Translocated Position in Human Leukemias (1986) (0)
Heteroatom-containing resveratrol derivatives as ceramide-mediated antiproliferative agents (2007) (0)
Updated selection of unrelated donor (2013) (0)
Structural Requirements of Synthetic Resveratrol Analogues for Ceramide-Mediated Proapoptotic Activity on Human Metastatic Breast Cancer Cells (2005) (0)
Abstract 4532: Deregulation of retinoic acid (RA) epigenetic control of sphingolipid signaling (2016) (0)
Comparative mapping ofDNA markers fromthefamilial Alzheimer disease andDownsyndrome regions ofhumanchromosome 21to mousechromosomes 16and17 (1988) (0)
Abstract 4479: Cancer cell ribogenesis: MYC and the integrity of the RNA polymerase I-rRNA machinery (2017) (0)
Concerted silencing of vitamin A genes in breast epithelial cells: Implications for cancer prevention. (2006) (0)
Quality of Cord-Blood Units and Hematological Recovery After Intra Bone CBT Are Not Influenced by the Bank of Origin and by the Time of Cryopreservation (2011) (0)
HumanETS2geneonchromosome 21isnotrearranged in Alzheimer disease (1988) (0)
Abstract 3568: Induction of aberrant breast acinar morphogenesis by deregulation of an estrogen receptor alpha circadian circuit. (2013) (0)
Differentiation of pre-B and pre-T leukemic lines by phorbol ester (1985) (0)
Metabolism of storage proteins and isoenzyme variation in Phaseolus embryo in culture. (1980) (0)
Abstract A19: Identification of epigenetic hits can predict breast cancer risk (2008) (0)
Development of epigenetic resistance to retinoic acid in breast cancer : implications for chemoprevention (2003) (0)
Contribution of somatic cell genetics techniques and quantitative cytochemical analysis to studies and diagnosis of inborn errors of metabolism. (1979) (0)
Abstract 180: Expanding the definition of core binding factor leukemia (2015) (0)
Abstract 2497: Upregulation of annexin A8 is a common molecular phenotype of aberrant breast acinar morphogenesis induced by different genetic factors. (2013) (0)
RAR Beta Methylation and Loss of RAR Beta Expression in Breast Cancer (2000) (0)
Synthetic hydroxylated aryl-naphthalene derivatives as resveratrol rigid analogues showing ceramide-mediated antiproliferative and pro-apoptotic properties (2005) (0)
AD Award Number : DAMD 17-021-0432 TITLE : Modulation of Breast Tumor Cell Response to Retinoids by Histone Deacetylase Inhibitors (0)
Modulation of Breast Tumor Cell Response to Retinoids by Histone Deacetylase Inhibitors (2003) (0)
Impaired Retinoic Acid (RA) Signal Leads to RAR (cid:2) 2 Epigenetic Silencing and RA Resistance (2005) (0)
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia (2015) (0)
Effect of nucleosides on human T and B lymphoblastoid cell lines. (1982) (0)
Erratum: Training practices of hematopoietic progenitor cell–apheresis and –cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation (2015) (0)
Impairment of Retinoic Acid Receptor-Ceramide Signaling in Retinoic Acid-Resistant Breast Cancer Cells. Implications for Retinoid Differentiation Therapy of Breast Cancer (2003) (0)
Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study (2021) (0)
Abstract LB-93: The epigenetic basis of the tumorigenic action of retinoic acid (2010) (0)
Permissive HLA-DPB1 Mismatch and Survival after Unrelated Donor Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Comparative Analysis of Different Immunogenetic Models on 422 Patients from GITMO and IBMDR (2018) (0)
DNA synthesis catalyzed in vitro by yeast extracts using A 2 μm DNA containing plasmid as template for enzymatic DNA synthesis (1982) (0)
Silencing of retinoic acid signaling to test for the presence of early signs of malignancy in morphologically “normal” breast epithelial cells (2007) (0)
Harnessing 3 D models of mammary epithelial morphogenesis . An off the beaten path approach to identify candidate biomarkers of early stage breast cancer (2016) (0)
Scheduled and unscheduled DNA synthesis in human leukemic cell lines positive and negative for terminal deoxynucleotidyl transferase (1979) (0)
The species and tissue specificity of the intracellular exchange of lysosomal enzymes (1981) (0)
Audit of donor centre: guidelines by the World Marrow Donor Association Quality and Regulation Working Group (2022) (0)
High Resolution Donor/Recipient HLA Matching Level in Unrelated Hematopoietic Stem Cell Transplantation and Impact on the Transplant Outcome: The Italian Experience on Behalf of GITMO, IBMDR and Aibt (2018) (0)
qPCR Applications for the Determination of the Biological Age. (2020) (0)
The use of hypertonic media in selecting somatic cell hybrids (1976) (0)
Proceedings: Effect of streptolydigin on chromosome complements of human cells cultured in vitro. (1975) (0)
Induction of RARB2 epigenetic silencing leads to development of retinoic acid resistance in cancer cells (2004) (0)
Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study. (2007) (0)
Abstract 1401: Deterring breast cancer progression. The critical role of a lipid-sphingolipid epigenetic mechanism of cell fate (2017) (0)
Significance of Lineage-Associated Transcripts of TdT and ETS1 for Detection of Leukemic Cells (1994) (0)
Detection of the AML translocation (8;21) by two-color fluorescent in situ hybridization (1994) (0)
Complementation studies on fibroblasts of Lesch-Nyhan patients by means of somatic cell hybridization (1979) (0)
Exon trapping of internal and 3{prime}-terminal exons from a YAC containing the AML1 gene (1994) (0)
Evidence of epigenetic changes a(cid:128)ecting the chromatin state of the retinoic acid receptor b 2 promoter in breast cancer cells (2000) (0)
Resveratrol impairs the 3D aggregation of MDA-MB-231 through a ceramide-mediated mechanism (2004) (0)
Abstract 4203: Retinoic acid signal and annexins: A vicious circle of breast tumorigenesis (2015) (0)
Targeting epigenetic changes associated with retinoid resistance : a novel strategy to treat breast cancer (2001) (0)
Precise localization of the chromosome 21 Hu-ETS-2 gene to the critical regions of chromosome 21 in t(8;21) AML and Down Syndrome (1986) (0)
Giuseppe Bigi (1944–2002) (2007) (0)
Disruption of circadian rhythm in breast tumorigenesis (2008) (0)

This paper list is powered by the following services:

Other Resources About Nicoletta Sacchi

en.wikipedia.org

What Schools Are Affiliated With Nicoletta Sacchi?

Nicoletta Sacchi is affiliated with the following schools:

Nicoletta Sacchi's Academic­Influence.com Rankings

Nicoletta Sacchi's Degrees

Why Is Nicoletta Sacchi Influential?

Nicoletta Sacchi's Published Works

Published Works

Other Resources About Nicoletta Sacchi

What Schools Are Affiliated With Nicoletta Sacchi?

Nicoletta Sacchi's AcademicInfluence.com Rankings